Hemophilia A and Nuwiq®: Frequently Asked Questions
Click here to view the video
This video shows patients how to prepare an injection of Nuwiq®. It is available for the Hemophilia Centre to use when training a patient that will be receiving Nuwiq®. This video should also be used alongside information provided in the packages of Nuwiq®.
Interested in a home infusion support program? Talk to your hemophilia treatment team for more information.
As dosage and treatment duration depend on your clinical situation, the type and severity of your bleeding and your FVIII:C levels, your physician will decide on your treatment on an individual basis.
General dosing recommendations:
No symptom of overdose has been reported.
In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.
It is important to take the total daily dose prescribed to ensure you get maximum benefit. If you miss a dose, take the missed dose as soon as possible, and then continue as before. However, if a dose is skipped, do not double the next dose. Continue on with your normal dose on the regular schedule as prescribed by your doctor.
Talk to your hemophilia treatment team for guidance on optimal Nuwiq dosing for your needs.
Allergic reactions such as hives and itching can occur at the injection site with Nuwiq®. If these symptoms occur contact your doctor or pharmacist for advice before continuing treatment. In rare cases, the allergic reactions are severe, known as shock or anaphylactic shock. This may include extreme difficulty breathing, or loss of consciousness. Urgent treatment is required and the emergency services should be called, for example 911.
Development of inhibitors is a known complication in the treatment of hemophilia A.
Inhibitors are antibodies that block the activity of factor VIII, reducing the efficacy of Nuwiq® in prevention or control of bleeding. If your bleeding is not controlled with Nuwiq®, tell your doctor immediately. Tests should be performed to determine if the inhibitors are present.
This is not a complete list of side effects.
For any unexpected effects while taking Nuwiq®, contact your doctor, hemophilia nurse or pharmacist. You can also report suspected side effects directly to the Canada Vigilance Program by calling 1-866-234-2345.
Copyright © 2018 Octapharma I
Legal Statement I
Privacy Statement I Sitemap
Octapharma Canada Inc. | 308 - 214 King Street West | Toronto, ON | M5H 3S6